Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Engelhardt

Showing results (41-50 of 226) with videos related to

Pageof 23
Sort By:
Annals of Hematology|October 14, 2004
Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiologyAntonia M S Müller, Gabriele Ihorst, Roland Mertelsmann, et al.
Annals of Hematology|September 23, 2024
Response to daratumumab-retreatment in patients with multiple myelomaLaura Souren, Gabriele Ihorst, Christine Greil, et al.
Expert Opinion on Biological Therapy|June 8, 2013
Preclinical models of multiple myeloma: a critical appraisalJulia Schüler, Daniel Ewerth, Johannes Waldschmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2015
Conditional Survival: A Useful Concept to Provide Information on How Prognosis Evolves over TimeStefanie Hieke, Martina Kleber, Christine König, et al.
International Journal of Cancer|November 8, 2008
Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatmentAnna Markert, Véronique Thierry, Martina Kleber, et al.
Annals of Hematology|March 9, 2004
Striking complete remission after interferon-alpha for secondary recurrent non-Hodgkin's lymphoma but rare interferon-induced side effectsBarbara Deschler, Martin Reincke, Thorsten A Bley, et al.
Pharmacotherapy|July 19, 2013
Posaconazole therapeutic drug monitoring in the real-life setting: a single-center experience and review of the literatureBarbara N Gross, Gabriele Ihorst, Manfred Jung, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2006
State of the art therapy in multiple myeloma and future perspectivesUlrich Denz, Peter S Haas, Ralph Wäsch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2020
COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatmentRick Dersch, Thomas Wehrum, Sebastian Fähndrich, et al.
Cell Cycle (Georgetown, Tex.)|January 5, 2012
Monitoring APC/C activity in the presence of chromosomal misalignment in unperturbed cell populationsDominik Schnerch, Marie Follo, Julika Krohs, et al.
Pageof 23

Showing results (41-50 of 226) with videos related to

Sort By:
Pageof 23
Annals of Hematology|October 14, 2004
Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiologyAntonia M S Müller, Gabriele Ihorst, Roland Mertelsmann, et al.
Annals of Hematology|September 23, 2024
Response to daratumumab-retreatment in patients with multiple myelomaLaura Souren, Gabriele Ihorst, Christine Greil, et al.
Expert Opinion on Biological Therapy|June 8, 2013
Preclinical models of multiple myeloma: a critical appraisalJulia Schüler, Daniel Ewerth, Johannes Waldschmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2015
Conditional Survival: A Useful Concept to Provide Information on How Prognosis Evolves over TimeStefanie Hieke, Martina Kleber, Christine König, et al.
International Journal of Cancer|November 8, 2008
Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatmentAnna Markert, Véronique Thierry, Martina Kleber, et al.
Annals of Hematology|March 9, 2004
Striking complete remission after interferon-alpha for secondary recurrent non-Hodgkin's lymphoma but rare interferon-induced side effectsBarbara Deschler, Martin Reincke, Thorsten A Bley, et al.
Pharmacotherapy|July 19, 2013
Posaconazole therapeutic drug monitoring in the real-life setting: a single-center experience and review of the literatureBarbara N Gross, Gabriele Ihorst, Manfred Jung, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2006
State of the art therapy in multiple myeloma and future perspectivesUlrich Denz, Peter S Haas, Ralph Wäsch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2020
COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatmentRick Dersch, Thomas Wehrum, Sebastian Fähndrich, et al.
Cell Cycle (Georgetown, Tex.)|January 5, 2012
Monitoring APC/C activity in the presence of chromosomal misalignment in unperturbed cell populationsDominik Schnerch, Marie Follo, Julika Krohs, et al.
Pageof 23